MEDIUMVulnerability
Global
FDA Weighing Possible Regs for GenAI Medical Devices
·Source: Bank Info Security
Updated:
Executive Summary
Agency Seeks Public Input on Risk-Based Oversight Approach Across Product Life Cycle The U.S. Food and Drug Administration is seeking public feedback on the varying risks and other considerations involving generat
Analysis
Agency Seeks Public Input on Risk-Based Oversight Approach Across Product Life Cycle The U.S. Food and Drug Administration is seeking public feedback on the varying risks and other considerations involving generative artificial intelligence-enabled medical devices to inform the agency as it contemplates how to advance a regulatory approach for these evolving products.